'We're not a vant': Axovant seeks to forget the past as the company rebrands to Sio Gene Therapies
The company announced Tuesday it will now be called Sio Gene Therapies as it completes what’s been a three-year pivot away from Alzheimer’s disease and toward, well, gene therapy. Sio’s new name, pronounced s-EYE-oh, will go into effect Friday, with its new Nasdaq ticker $SIOX replacing its old symbol at market open.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 102,100+ biopharma pros reading Endpoints daily — and it's free.